Induction of antitumor cytotoxic activity using CD34+ cord blood cell- derived and irradiated tumor cell-primed dendritic cells

International Journal of Hematology

Volumn 68, Issue 2, 1998, Pages 169-182

  Fujii, Shin Ichiro ^a   Fujimoto, Koji ^a   Osato, Motomi ^a   Matsui, Kazuo ^b   Takatsuki, Kiyoshi ^a   Kawakita, Makoto ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b Fukuda Hospital   (Japan)

Author keywords

Cord blood cell; Dendritic cell; Immunotherapy

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TUMOR NECROSIS FACTOR ALPHA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CELL SPECIFICITY; CELL STRAIN K 562; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; HUMAN; HUMAN CELL; MONOCYTE; NATURAL KILLER CELL; NEWBORN; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TUMOR CELL DESTRUCTION; UMBILICAL CORD BLOOD;

EID: 0031727263     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0925-5710(98)00069-3     Document Type: Article

References (51)

1. Wagner J, Kernan N, Steibuch M, Broxmeyer H, Gluckman E Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet. 346:1995;214-219.
2. Sweetman R, Rosenthal J, Sender L, Cairo M. Successful engraftment delayed immune reconstitution and minimal GVHD following unrelated cord blood transplantation (UCBT) in children and adults (9-54 kg). Blood 1995;86:388a (abstr).
3. Wagner J, Rosenthal J, Sweetman R, Shu X, Davies S, Ramsay N, McGlave P, Sender L, Cairo M Successful transplantation of HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood. 88:1996;795-802.
4. Tucci A, Mouzaki A, James H, Bonnefoy J-Y, Zubler RH Are cord blood B cells functionally mature? Clin Exp Immunol. 84:1991;389-394.
5. Taylor S, Bryson YJ Impaired production of γ-interferon by newborn cells in vitro is due to a functionally immature macrophage. J Immunol. 134:1985;1493-1497.
6. Hunt DW, Huppertz HI, Jiang HJ, Petty RE Studies of human cord blood dendritic cells: evidence for functional immaturity. Blood. 84:1994;4333-4343.
7. Harris D, Schumacher M, Locascio J, Besencon F, Olson G, DeLuca D, Shenker L, Bard J, Boyse E Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Proc Natl Acad Sci USA. 89:1992;10006-10010.
8. Harris D, LoCascio J, Besencon F Analysis of the alloreactive capacity of human umbilical cord blood: Implications for graft-versus-host disease. Bone Marrow Transplant. 14:1994;545-553.
9. Risdon G, Gaddy J, Stehman F, Broxmeyer H Proliferative and cytotoxic responses of human cord blood T lymphocytes following allogeneic stimulation. Cell Immunol. 154:1994;14-21.
10. Risdon G, Gaddy J, Horie M, Broxmeyer H Alloantigen priming induces a state of unresponsiveness in human umbilical cord blood T cells. Proc Natl Acad Sci USA. 92:1995;2413-2417.
11. Marmont AM, Horowitz MM, Gale RP, Sobocinski K, Ash RC, van Bekkum DW, Champlin RE, Dicke KA, Goldman JM, Speck B, Weiner RS, Bortin MM T cell depletion of HLA-identical transplants in leukemia. Blood. 78:1991;2120-2130.
12. Kolb H, Mittermuller J, Clemm C, Holler E, Ledrerose G, Brehm G, Heim M, Wilmanns W Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood. 76:1990;2462-2465.
13. Porter D, Roth M, McGarigle C, Ferrara J, Antin J Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. New Engl J Med. 330:1994;100-106.
14. van Rhee F, Lin F, Cullis J, Spencer A, Cross N, Chase A, Garicochea B, Bungey J, Barrett J, Goldman J Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: The case for giving donor leukocyte transfusions before the onset of hematologic relapse. Blood. 83:1994;3377-3383.
15. Korngold R, Leighton C, Manser T Graft-versus-myeloid leukemia response following syngeneic and allogeneic bone marrow transplantation. Transplantation. 58:1994;278-287.
16. + cytotoxic T-lymphocyte clones from a patient with severe graft-versus-host disease after allogeneic bone marrow transplantation: Implications for graft-versus-leukemia reactivity. Blood. 86:1995;2821-2828.
17. Hauch M, Gazzola M, Small T, Bordignon C, Barnett L, Cunningham I, Castro-Malaspinia H, O'Reilly R, Keever C Antileukemia potential of interleukin-2 activated natural killer cells after bone marrow transplantation for chronic myelogeneous leukemia. Blood. 75:1990;2250-2262.
18. Hercend T, Takvorian T, Nowill A, Tantravahi R, Moingeon P, Anderson K, Murray C, Bohuon C, Ythier A, Ritz J Characterization of natural killer cells with antileukemia activity following allogeneic bone marrow transplantation. Blood. 67:1986;722-728.
19. Wiltschke C, Krainer M, Wagner A, Linkesch W, Zielinski CC Influence of in vivo administration of GM-CSF and G-CSF on monocyte cytotoxicity. Exp Hematol. 23:1995;402-406.
20. Vogelsang G, Hess A Graft-versus-host disease: New directions for a persistent problem. Blood. 84:1994;2061-2067.
21. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, Rimm AA, Ringden O, Rozman C, Speck B, Truitt RL, Zwaan FE, Bortin MM Graft-versus-leukemia reactions after bone marrow transplantation. Blood. 75:1990;555-562.
22. van Lochem E, de Gast B, Goulmy E In vitro separation of host specific graft-versus-host and graft-versus-leukemia cytotoxic T cell activities. Bone Marrow Transplant. 10:1992;181-183.
23. Lewis DB, Yu CC, Meyer J, English BK, Kahn SJ, Wilson CB Cellular and molecular mechanisms for reduced interleukin 4 and interferon-γ production by neonatal T cells. J Clin Invest. 87:1991;194-202.
24. Mayordomo JI, Zorina T, Storkus WJ, Zitvogel L, Celluzzi C, Falo LD, Melief CJ, Ildstad ST, Kast WM, Deleo AB, Lotze MT Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nature Med. 1:1995;1297-1302.
25. Celluzzi CM, Mayordomo JI, Storkus WJ, Lotze MT, Falo LJ Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J Exp Med. 183:1996;283-287.
26. Porgador A, Snyder D, Gilboa E Induction of antitumor immunity using bone marrow-generated dendritic cells. J Immunol. 156:1996;2918-2926.
27. Hsu FJ, Benike C, Fagnoni F, Liles TM, Czerwinski D, Taidi B, Engleman EG, Levy R Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nature Med. 2:1996;52-58.
28. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature. 360:1992;258-261.
29. + progenitors in human bone marrow. J Immunol. 149:1992;2681-2688.
30. + hematopoietic progenitor cells of the bone marrow and peripheral blood. Cancer Res. 55:1995;1099-1104.
31. Matsuo Y, Ariyasu T, Adachi T, Tsubota T, Minowada J Two t(9;22) leukemia cell lines (NALM-24 and NALM-25) with biphenotypic characteristics and an EBV-positive B-cell non-leukemia cell line (B262) established from a patient with acute lymphoblastic leukemia. Hum Cell. 4:1991;339-342.
32. Faber LM, Van Luxemburg-Heijs SAP, Willemze R, Falkenburg JHF Generation of leukemia reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia. J Exp Med. 176:1992;1283-1289.
33. + hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNFα J Exp Med. 184:1996;695-706.
34. Cross NCP, Melo JV, Feng L, Goldman JM An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in haematological disorders. Leukemia. 8:1994;186-189.
35. + blood dendritic cells. Blood. 86:1995;3295-3301.
36. + T cells. J Immunol. 154:1995;5071-5079.
37. Heufler C, Koch F, Stanzl U, Topar G, Wysocka M, Trinchieri G, Enk A, Steinman R, Romani N, Schuler G Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-g production by T helper 1 cells. Eur J Immunol. 26:1996;659-668.
38. Trinchieri G Interleukin-12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood. 84:1994;4008-4027.
39. Bouwens L, Remels L, Baekeland M, Van Bossuyt H, Wisse E Large granular lymphocytes or 'pit cells' from rat liver: isolation, ultrastructural characterization and natural killer activity. Eur J Immunol. 17:1987;37-42.
40. + IL-2-activated natural killer cells. Nature. 358:1992;66-70.
41. Smith KD, Lutz CT Alloreactive T cell recognition of MHC class I molecules. The T cell receptor interacts with limited regions of MHC class I long α helics. J Immunol. 158:1997;2805-2812.
42. Sosman J, Oettel K, Smith S, Hank J, Fisch P, Sondel P Specific recognition of human leukemic cells by allogeneic T cells: II. Evidence for HLA-D restricted determinants on leukemic cells that are crossreactive with determinants present on unrelated nonleukemic cells. Blood. 75:1990;2005-2016.
43. Bocchia M, Wentworth P, Southwood S, Sidney J, McGraw K, Scheinberg D, Sette A Specific binding of leukemia oncogene fusion protein peptides to HLA class I molecules. Blood. 85:1995;2680-2684.
44. Bocchia M, Korontsvit T, Xu Q, Mackinnon S, Yang S, Sette A, Scheinberg D Specific human cellular immunity to bcr-abl oncogene-derived peptides. Blood. 87:1996;3587-3592.
45. Greco G, Fruci D, Accapezzato D, Barnaba V, Nisini R, Alimena G, Montefusco E, Vigneti E, Butler R, Tanigaki N, Tosi R Two bcr-abl junction peptides bind HLA-A3 molecules and allow specific induction of human cytotoxic T lymphocytes. Leukemia. 10:1996;693-699.
46. Inaba K, Inaba M, Naito M, Steinman R Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J Exp Med. 178:1993;479-488.
47. Matsuno K, Ezaki T, Kudo S, Uehara Y A life stage of particle-laden rat dendritic cells in vivo: Their terminal division, active phagocytosis, and translocation from the liver to the draining lymph. J Exp Med. 183:1996;1865-1878.
48. Scheicher C, Mehlig M, Dienes HP, Reske K Uptake of microparticle-adsorbed protein antigen by bone marrow-derived dendritic cells results in up-regulation of interleukin-1 alpha and interleukin-12 p40/p35 and triggers prolonged, efficient antigen presentation. Eur J Immunol. 25:1995;1566-1572.
49. van de Loosdrecht A, Ossenkoppele G, Beelen R, Broekhoven M, van Hooff M, Drager A, Huijgens P, Langenhuijsen M Maturation-dependent susceptibility to monocyte-mediated cytotoxicity in acute myeloid leukemia. Leukemia. 8:1994;1392-1400.
50. Ushio Y, Yamamoto N, Sanchez-Bueno A, Yoshida R Failure to reject an allografted tumor after elimination of macrophages in mice. Microbiol Immunol. 40:1996;489-498.
51. John EW, Joseph R, Robert S, Xiao OS, Stella MD, Norma KCR, Philip BMG, Leonard S, Mitchell SC Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood. 83:1996;795-802.